Aug 9th, 2020 - In this hypothesis, we address the biological/immunological pathway leading to severe disease or death after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The underlying immune response is described with "original antigenic sin" (OAS) whereby previous infections influence the response to future virus encounters. We cite evidence for OAS-induced immunopathology in ...

Aug 8th, 2020 - Risk and prognosis of COVID-19 in patients treated with renin-angiotensin-aldosterone inhibitors.|2020|Vistisen ST,Bodilsen J,Scheeren TWL,Simonsen U,|

Aug 8th, 2020 - What's Important: Is "Spring Training" Necessary for Surgeons After a Long COVID-19 Off-Season?|2020|Schultz RA,Lachiewicz PF,|

Aug 8th, 2020 - How to Manage Pediatric Orthopaedic Patients: Strategies to Provide Safer Care During the COVID-19 Outbreak in Wuhan, People's Republic of China.|2020|Li J,Shen X,Shao J,Ze R,Rai S,|

Aug 8th, 2020 - Currently, the coronavirus disease 2019 (COVID-19) crisis has rapidly spread worldwide. As the earliest outbreak area of the pandemic, Wuhan, People's Republic of China, is gradually recovering to its normal state under the effective control of government authorities. Outpatient services in major hospitals are now being restored. An accumulation of asymptomatic infections is a potential risk fo...

Aug 8th, 2020 - Philosophy Problems Become Real During the COVID-19 Pandemic.|2020|Randall RM,Rafferty R,|

Aug 8th, 2020 - COVID-19 - Is It Time for Exercise Clinicians to Prehabilitate "High Risk" Respiratory Patients?|2020|Ahmed I,Haji G,|

Aug 8th, 2020 - COVID-19 and the School-based Mass Preparticipation Physical Evaluation: The Anvil That Broke the Camel's Back?|2020|Cunningham A,|

Aug 8th, 2020 - ACSM Call to Action Statement: COVID-19 Considerations for Sports and Physical Activity.|2020|Denay KL,Breslow RG,Turner MN,Nieman DC,Roberts WO,|

Aug 8th, 2020 - Immunity, inflammation and the vasculature in the COVID-19 era.|2020|Schutte AE,Harrison DG,|

Aug 8th, 2020 - The use of nonpharmaceutical interventions can prevent viral spread in COVID-19 pandemic and PPE forms a crucial part of this strategy. However, there are discrepancies in existing guidelines and a lack of consensus among ophthalmic communities. This review aims to identify general consensus and provides recommendation of PPE for most common ophthalmological scenarios. With a global shortage of...

Aug 8th, 2020 - Coinfection of severe acute respiratory syndrome coronavirus 2 and HIV in a teaching hospital: still much to learn.|2020|Sasset L,Di Meco E,Cavinato S,Cattelan AM,|

Aug 8th, 2020 - Coronavirus disease 2019 in patients with HIV in the province of Araba, Basque Country, Spain.|2020|Molina-Iturritza E,San-José-Muñiz I,Ganchegui-Aguirre M,Balerdi-Sarasola L,Ortiz-de-Zárate-Ibarra Z,|

Aug 8th, 2020 - On March 11, 2020, World Health Organization announced that severe acute respiratory syndrome coronavirus 2 caused COVID-19 was a global pandemic. COVID-19 is associated with venous thromboembolism including deep vein thrombosis and pulmonary embolism. To further identify the current role of antiplatelet/anticoagulant therapy in the prophylaxis and treatment of COVID-19 patients is important. W...

Aug 8th, 2020 - Assessing the effectiveness and safety of Tai Chi for coronavirus disease 2019 (COVID-19) in recovery period is the main purpose of this systematic review protocol. The following electronic databases will be searched from inception to April 2020: MEDLINE, Ovid, EMBASE, the Cochrane Library, the Allied and Complementary Medicine Database, Chinese National Knowledge Infrastructure, Chinese Biomed...

Aug 8th, 2020 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to be a threat to the health of many humans across the world as they confront coronavirus disease 2019 (COVID-19). Previous promising in vitro data that emerged after the SARS-CoV outbreak in 2003, along with the emergent need for pharmacologic management strategies in the fight against COVID-19, prompted interest in the use...

Aug 8th, 2020 - In May 2020 the Russian Ministry of Health granted fast-track marketing authorization to RNA polymerase inhibitor AVIFAVIR (favipiravir) for the treatment of COVID-19 patients. In the pilot stage of Phase II/III clinical trial, AVIFAVIR enabled SARS-CoV-2 viral clearance in 62.5% of patients within 4 days, and was safe and well-tolerated.

Aug 8th, 2020 - This study aimed to evaluate the onset characteristics of patients with uremia undergoing maintenance hemodialysis complicated with COVID-19, so as to improve the understanding, diagnosis, and treatment.26 cases were confirmed cases of COVID-19. Confirmed patients with COVID-19 undergoing maintenance hemodialysis in the blood purification center were recruited. The general data of patients, inc...

Aug 8th, 2020 - Novel coronavirus disease (COVID-19) emerged in Wuhan in December 2019, has spread in many countries affected people globally. In response to the economic requirement of the nation and meet the need of patient's, a momentous event was going back to work step by step as fighting against COVID-19. Safety in clinical work is of priority as elective surgery in the department of surgery progressing....

Aug 8th, 2020 - Macrophage activation syndrome (MAS) is a rare life-threatening condition characterized by cytokine-mediated tissue injury and multiorgan dysfunction. We describe the unique case of young man who developed MAS as the sole manifestation of an otherwise paucisymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Clinical and biological criteria led to the diagnosis of...